- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07531836
Multikomponentní prehabilitace u starších dospělých s karcinomem prsu (PREHAB-BC65)
Multidimensional Oncogeriatric Prehabilitation in Older Adults With Breast Cancer: A Randomized Controlled Trial Integrating Frailty and Biomarker Assessment
Older adults with breast cancer frequently present with frailty, decreased functional reserve, and increased risk of postoperative complications. Prehabilitation programs have emerged as a promising strategy to improve physical function and clinical outcomes; however, evidence in geriatric oncology remains limited, particularly regarding the role of biological markers in predicting response to such interventions.
This study aims to evaluate the effectiveness of a multicomponent prehabilitation program in older adults with breast cancer, focusing on functional status, clinical outcomes, and quality of life. In addition, the study seeks to characterize biological markers associated with frailty and treatment response, with the goal of identifying potential predictors of benefit from prehabilitation.
Participants will undergo a structured prehabilitation intervention including physical exercise, nutritional optimization, and comprehensive geriatric assessment. Clinical, functional, and biomarker data will be collected longitudinally.
The results of this study may contribute to improving personalized care strategies in geriatric oncology and to identifying patients who are most likely to benefit from prehabilitation programs.
Přehled studie
Postavení
Detailní popis
This study is a prospective, randomized, controlled, single-blind clinical trial designed to evaluate the effectiveness of a multicomponent prehabilitation program in older adults with breast cancer, incorporating biological characterization to explore predictors of treatment response.
The trial will be conducted at the Navarre University Hospital (Pamplona, Spain). A total of 90 ambulatory patients aged 65 years or older with a confirmed diagnosis of breast cancer will be recruited and randomly assigned in a 1:1:1 ratio to usual care, a home-based multicomponent exercise program based on the Vivifrail methodology, or a supervised hospital-based intervention. All participants will undergo baseline frailty screening followed by a comprehensive geriatric assessment to characterize functional, cognitive, nutritional, and clinical status. Assessments will be repeated at predefined time points throughout the perioperative period and during follow-up.
The intervention is structured into preoperative and postoperative phases and includes individualized multicomponent exercise, nutritional optimization, and targeted management of geriatric syndromes. The hospital-based intervention consists of supervised sessions over six weeks (including a 2-week preoperative phase and a 4-week postoperative phase), while the home-based intervention is adapted to baseline functional status.
Clinical, functional, and biological data will be collected longitudinally to evaluate the impact of the intervention and to identify predictors of clinical outcomes and treatment response.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
- Jméno: Marta Lorente Escudero, MD
- Telefonní číslo: +34 648148503
- E-mail: marta.lorente.escudero@navarra.es
Studijní záloha kontaktů
- Jméno: Nicolás Martínez Velilla, PhD
- Telefonní číslo: +34 670900434
- E-mail: nicolas.martinez.velilla@navarra.es
Studijní místa
-
-
Navarre
-
Pamplona, Navarre, Španělsko, 31008
- Nábor
- Hospital Universitario de Navarra
-
Kontakt:
- Marta Lorente Escudero, MD
- Telefonní číslo: +34 648148503
- E-mail: marta.lorente.escudero@navarra.es
-
Kontakt:
- Nicolás Martínez Velilla, MD, PhD
- Telefonní číslo: +34 670900434
- E-mail: nicolas.martinez.velilla@navarra.es
-
Vrchní vyšetřovatel:
- Nicolás Martínez Velilla, MD, PhD
-
Dílčí vyšetřovatel:
- Bernardo Abel Cedeño Veloz, MD, PhD
-
Dílčí vyšetřovatel:
- Susana de la Cruz Sánchez, MD
-
Dílčí vyšetřovatel:
- Sara Esteban Gordillo, MD
-
Dílčí vyšetřovatel:
- Natalia Moras Pérez, MD
-
Dílčí vyšetřovatel:
- Fabricio Zambom Ferraresi, PhD
-
Dílčí vyšetřovatel:
- Marta Lorente Escudero, MD
-
Dílčí vyšetřovatel:
- Lucía Lozano Vicario, MD, PhD
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Age ≥65 years
- Diagnosis of breast cancer requiring elective surgery with curative intent
- Candidate for prehabilitation program before surgery
- Ability to walk (with or without assistive devices)
- Ability to provide informed consent
Exclusion Criteria:
- Urgent or emergency surgery
- Severe cognitive impairment precluding participation in the intervention
- Severe functional dependency (e.g., bedridden patients)
- Medical contraindication to physical exercise
- Life expectancy <3 months
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Žádný zásah: Usual Care
Participants receive standard clinical care according to routine practice, including management by oncology and surgical teams. Identified geriatric conditions are communicated to the treating physician for appropriate management. |
|
|
Experimentální: Home-based Multicomponent Prehabilitation (Vivifrail)
Participants perform a home-based multicomponent exercise program based on the Vivifrail methodology, including strength, endurance, balance, and flexibility training over six weeks, comprising a 2-week preoperative phase and a 4-week postoperative phase. The program is tailored according to baseline functional status and supported by caregiver supervision. Participants also receive comprehensive geriatric assessment and nutritional optimization. |
Participants perform a structured home-based multicomponent exercise program based on the Vivifrail methodology, including strength, endurance, balance, and flexibility training over six weeks. The program is individualized according to baseline functional status. Participants undergo comprehensive geriatric assessment with targeted interventions including nutritional optimization, medication review, and management of geriatric syndromes. |
|
Experimentální: Supervised Multicomponent Prehabilitation
Participants receive a supervised multicomponent exercise program delivered in the hospital setting, including aerobic, resistance, balance, and flexibility training over six weeks, including a 2-week preoperative phase and a 4-week postoperative phase. The intervention is combined with comprehensive geriatric assessment, nutritional optimization, and individualized management of geriatric syndromes. |
Participants undergo comprehensive geriatric assessment with targeted interventions including nutritional optimization, medication review, and management of geriatric syndromes. Participants receive a structured, supervised multicomponent exercise program delivered in a hospital setting, including aerobic, strength, balance, and flexibility training over six weeks. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in physical function assessed by Short Physical Performance Battery (SPPB)
Časové okno: Baseline to the end of the 6-week intervention period
|
Physical function will be assessed using the Short Physical Performance Battery (SPPB), a validated tool in older adults (score range 0-12, higher scores indicate better performance). The primary outcome will be the change in SPPB score from baseline to the end of the 6-week intervention period. |
Baseline to the end of the 6-week intervention period
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Incidence of postoperative complications
Časové okno: Within 30 days after surgery
|
Occurrence of postoperative complications within 30 days after surgery, classified according to the Clavien-Dindo classification. |
Within 30 days after surgery
|
|
Length of hospital stay
Časové okno: From date of surgery until hospital discharge, with a maximum follow-up of 30 days postoperatively
|
Number of days from surgery to hospital discharge. |
From date of surgery until hospital discharge, with a maximum follow-up of 30 days postoperatively
|
|
Functional decline after surgery
Časové okno: Baseline to 30 days after surgery
|
Functional decline defined as a decrease in the Short Physical Performance Battery (SPPB) score (range 0 to 12, with higher scores indicating better physical performance) or loss of independence in activities of daily living compared to baseline. |
Baseline to 30 days after surgery
|
|
Health-related quality of life
Časové okno: Baseline to 30 days after surgery
|
Health-related quality of life assessed using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30; scores transformed to a 0-100 scale, where higher scores indicate better functioning or worse symptoms depending on the domain). |
Baseline to 30 days after surgery
|
|
Adherence to the intervention
Časové okno: During the 6-week intervention period
|
Percentage of prescribed exercise sessions completed by participants. |
During the 6-week intervention period
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Ředitel studie: Marta Lorente Escudero, MD, Navarre Health Service (SNS-O), Navarre University Hospital (HUN), Pamplona, Spain
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
- Neurologické projevy
- Nemoci nervového systému
- Neuromuskulární projevy
- Patologické procesy
- Novotvary podle místa
- Novotvary
- Patologické stavy, anatomické
- Kožní choroby
- Nemoci prsu
- Svalová atrofie
- Atrofie
- Patologické stavy, příznaky a symptomy
- Onemocnění kůže a pojivové tkáně
- Příznaky a symptomy
- Křehkost
- Novotvary prsu
- Sarkopenie
- Kvalita zdravotní péče, přístup a hodnocení
- Vyšetřovací techniky
- Epidemiologické metody
- Sběr dat
- Mechanismy hodnocení zdravotní péče
- Kvalita zdravotní péče
- Veřejné zdraví
- Životní prostředí a veřejné zdraví
- Charakteristiky populace
- Zdravotní stav
- Demografie
- Epidemiologická měření
- Geriatrické hodnocení
Další identifikační čísla studie
- HUN-PREHAB-BC-65
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Popis plánu IPD
Individual participant data will not be shared due to data protection regulations and institutional policies. De-identified data may be available from the corresponding author upon reasonable request, subject to ethical approval and data sharing agreements.
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .